CNS / Neurology

For this reason, among others, CNS clinical development programs have among the highest failure rates across all therapeutic areas. Quotient Sciences can support you minimizing development risk in your molecule's journey to a commercialized therapy with our expertise and global, CDMO/CRO services.

Working with you, we make it our mission to bring innovative and potentially life-changing medicines to those in need. With over 30 years of experience in drug development, our integrated preclinical, clinical pharmacology, drug product development and manufacturing expertise make us the ideal partner to get move your CNS forward, fast.

We are committed to helping you to address unmet clinical needs, with a comprehensive solution for the development of CNS therapeutics that covers candidate selection to commercial manufacturing. 

Choosing to partner with us means you can benefit from our extensive knowledge and unique integration in formulation development, clinical pharmacology, clinical manufacturing, and commercial manufacturing